BeStock  
Markets › Compare › VSTM vs PHAR

VSTM vs PHAR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
VSTM · Verastem$6.33 ▼ 7.73%
PHAR · Pharming Group$11.54 ▼ 5.18%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

305579104129Nov 24, '25May 26, '26Nov 20, '26
  • VSTM -35.7%
  • PHAR -32.6%

Head to head

MetricVSTMPHAR
Price$6.33$11.54
Change today▼ 7.73%▼ 5.18%
Market cap$797.67M$816.78M
Return, 3 months-7.7%+0.7%
Return, year to date-18.0%-34.7%
Return, 1 year-36.7%-29.0%
P/E (TTM)–35.0
P/B79.12.8
P/E percentile vs own 5y1st77th
Dividend yield––
Revenue growth (YoY, latest qtr)+113.6%+20.8%
Net profit growth (YoY)+24.2%+197.1%
Gross margin86.1%85.1%
Operating margin-193.7%6.7%
Net margin-178.4%6.3%
Return on equity–8.7%
Analyst target vs. price+192.3%+238.0%
Analyst buy share100%100%
RSI (14)2845
30-day volatility94.6%59.3%
Max drawdown, 1 year-67.6%-57.0%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • PHAR is the largest of the group by market value.
  • PHAR has returned the most over the past year.
  • VSTM is growing revenue fastest.
  • PHAR keeps the most profit per dollar of sales.
  • PHAR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top